MILS International
Breaking Diagnostic Barriers with Advanced Metabolic Screening
Dr. Chunhua Zhang, MD, PhD, Director
Clinical Testing Services
Clinical Testing Services are specialized healthcare and life sciences functions that design, conduct, and analyze diagnostic and trial-based evaluations of drugs, devices, and therapies. They ensure regulatory compliance, data integrity, and patient safety while enabling evidence-driven innovation, clinical validation, and commercialization across pharmaceutical, biotechnology, and medical technology ecosystems globally worldwide.
Solutions
Advanced metabolic biomarker detection is the next step in improving inborn errors of metabolism (IEM) diagnosis and patient outcomes. Traditional metabolic screening, including urine organic acid analysis and blood acylcarnitine profiling, often fails to reveal the full complexity of IEMs. With over 8,000 known rare diseases, 80 percent of which are hereditary, the need for comprehensive testing has never been more critical.
Leadership Perspective
Otsuka Pharmaceutical
Evolving Digital Biomarkers in Clinical Trial Space
Kazuto Yamada, Senior Director, Head of Clinical Development Planning and Supervising Five R&D Functions
Clinical trials have undergone significant changes over the decades, both strategically and operationally. These changes have been driven by advancements in technology and a recent emphasis on patient-centered outcomes. For instance, the direct data capture (DDC) methods haveenabled electronic data collectiondirectly from the source,whichis then automatically transferred to a central database for visualization, eliminating the need for source data verification (SDV). Artificial intelligence (AI) canalso play a role in the design and efficiency of non-traditional trials, such as ones incorporating the use of real world data (RWD). Additionally, blockchain technology has the potential to incentivize participants in clinical trials through token rewards or other forms of compensation.
Solutions
Seoul Clinical Laboratories (SCL)
Advancing Clinical Testing through AI and Digital Pathology
Kyoung-Ryul Lee, President & CEO
Seoul Clinical Laboratories (SCL) has been advancing in clinical diagnostics for over four decades and more recently through AI-driven prediction test service and digital pathology systems. These technologies are transforming how healthcare professionals detect and diagnose diseases, improving accuracy and speed. By enhancing workflows and providing deeper insights, SCL empowers clinicians to make faster, more confident decisions. Through its focus on advanced technologies, SCL ensures that medical professionals are equipped with the tools to provide better patient care.
Leadership Perspective
BeiGene
Challenges To Clinical System In China
Cheryl Chen, Director of Clinical Operations
In the past five years, the Clinical Trial has increasingly developed in China. When looking at the data from China CDE (Center for Drug Evaluation), we can see the number of Clinical Trials registered in CDE of 2021 has been more than twice of the number of 2017. The change is not only on the registration number. The new version of China Good Clinical Practice (GCP) has been issued in 2020, which has set a higher request to the quality of clinical trials running in China. Also in 2020, The State Council, China's cabinet, published a regulation on the management of human genetic resources, to supervise the systems with human genetic information in a strict process. With all these changes, the clinical system providers are accommodating in China markets to meet the challenges.
Clinical Testing Services Info
Q1
What Do Clinical Testing Services Companies Provide?
Top Clinical Testing Services support healthcare providers, pharmaceutical organizations, research institutions and diagnostic laboratories through specialized testing, analysis and reporting capabilities. These services may include pathology testing, biomarker analysis, genetic screening, metabolic diagnostics, infectious disease testing and clinical laboratory support. Many clinical testing providers also assist with sample processing, regulatory documentation and research validation activities. Accurate and timely testing plays an important role in disease detection, treatment planning and ongoing patient monitoring across medical and research environments.
Q2
What Services Are Commonly Included in Clinical Testing Services?
Top Clinical Testing Services often include laboratory diagnostics, specimen analysis, molecular testing, toxicology screening and clinical trial support. Some clinical laboratory service providers also offer mass spectrometry testing, metabolomics analysis and companion diagnostic development. Services may vary depending on the healthcare specialty, research focus or regulatory requirements involved. Clinical testing solutions are frequently used in hospitals, pharmaceutical research, preventive medicine programs and precision healthcare initiatives where reliable diagnostic data is essential for decision-making.
Q3
Why Is Demand Increasing for Clinical Testing Services?
Demand for Top Clinical Testing Services continues to grow because healthcare systems are placing greater emphasis on early diagnosis, personalized medicine and data-driven treatment strategies. Rising interest in rare disease detection, genetic testing and preventive healthcare has increased the need for advanced laboratory testing capabilities. Clinical testing technology has also expanded rapidly as healthcare organizations adopt biomarker-based diagnostics and precision medicine approaches. Regulatory approvals for newer diagnostic tools, including blood-based disease testing, demonstrate how clinical testing services are becoming more accessible and less invasive for patients.
Q4
How Are Top Clinical Testing Services Evaluated by Healthcare Organizations?
Healthcare providers and research organizations evaluating Top Clinical Testing Services often compare accuracy, turnaround times, regulatory compliance and testing breadth. Many buyers also assess laboratory certifications, quality assurance procedures and data reporting capabilities before selecting a provider. Clinical testing companies may additionally be reviewed based on technology infrastructure, integration support and expertise in specialized testing areas such as genomics, metabolomics or infectious disease diagnostics. Reliable communication and consistent result interpretation are also important factors in long-term laboratory partnerships.
Q5
What Value Do Clinical Testing Services Deliver to Healthcare and Research Organizations?
Top Clinical Testing Services can improve diagnostic confidence, accelerate treatment decisions and support better patient outcomes. Faster and more precise testing may reduce unnecessary procedures while helping clinicians identify diseases earlier in the care process. Clinical testing solutions also help pharmaceutical and biotechnology organizations strengthen research quality, monitor therapeutic effectiveness and support regulatory submissions. For hospitals and laboratories, dependable testing workflows can reduce delays, improve operational efficiency and enhance confidence in medical decision-making across clinical settings.
Q6
How Are Innovation and Technology Shaping Clinical Testing Services?
Innovation continues to influence Top Clinical Testing Services through advances in automation, molecular diagnostics, artificial intelligence and high-throughput laboratory technologies. Many clinical testing providers are adopting mass spectrometry, next-generation sequencing and cloud-based analytics to improve testing precision and scalability. Clinical testing technology is also supporting more personalized healthcare by enabling earlier detection of genetic and metabolic disorders. Expertise in data interpretation, laboratory science and regulatory standards has become increasingly valuable as healthcare organizations seek more sophisticated diagnostic capabilities and research support.
